Marion R. Wofford, MD, MPH, Herbert Gaines Langford Professorship in Medicine
Professor Emeritus
Department:
SOM-Medicine
Email:
mwofford@umc.edu
Work Phone:
(601) 984-5770
Education
| Harvard School of Public Health, MPH, Master of Public Health | 1998 |
| University of Mississippi Medical Center, Internal Medicine | 1997 |
| University of Mississippi Medical Center, Internal Medicine | 1996 |
| University of Mississippi School of Medicine, MD, Medicine | 1993 |
| Millsaps College, BS, Biology | 1978 |
Specialty Certification Licensure
| Re-certification, The American Board of Internal Medicine, The American Board of Internal Medicine | 2007 - 2017 |
| Licensure, Mississippi State Board of Medical Licensure | 07/1994 - 06/2011 |
| Certification, The American Board of Internal Medicine, The American Board of Internal Medicine | 1997 - 2007 |
Current Positions
| Medical Director of Adult Hospital, School of | 07/2013 - Present |
| Professor, School of Medicine, Department of Medicine | 07/2007 - Present |
| The University of Mississippi Medical Center Jackson, Mississippi 39216 | |
Academic Appointments or Other Previous Appointments
| Chief of Staff, UMMC, School of | 07/2012 - 06/2013 |
| Associate Professor, University of Mississippi Medical Center, School of Medicine, Department of Medicine | 2004 - 2007 |
| Associate Professor, University of Mississippi Medical Center, School of Graduate, Department of Medicine | 2003 - 2004 |
| Associate Professor, Unversity of Mississippi Medical Center, School of Medicine, Department of Medicine | 2003 - 2004 |
| Assistant Professor, University of Mississippi Medical Center, School of Medicine, Department of Medicine | 12/2002 - 2003 |
| Assistant Professor, University of Mississippi Medical Center, School of Medicine, Department of Medicine | 1997 - 2002 |
Sponsored Program Funding
| Intramural, Systolic Blood Pressure Intervention Trial. Sprint, NIH Subcontract with UAB, Birmingham | 09/2010 - 09/2018 |
| Extramural, The Effect of LY2189265 on Blood Pressure and Heart Rate, as Assessed by Ambulatory Blood Pressure Monitoring, in Patients with Type 2 Diabetes Mellitus. Protocol H9X-MC-GBDN, Eli Lilly and Company | 07/2010 - 06/2011 |
| Extramural, A Comparison of Prasugrel and Clopidogrel in Acute Coronary Syndrome Subjects with Unstable Angina/Non ST Elevation Myocardial Infarction Who are Medically Managed (Trilogy), Eli Lilly & Company | 08/2008 - 04/2011 |
| Extramural, A Phase III, Double-Blind, Randomized Placebo-Controlled Study to Evaluate the Effects of RO4607381 on Cardiovascular Risk in Stable CHD Patients with a Documented Recent Acute Coronary Syndrome, Hoffman-LaRoche, Inc. | 01/2008 - 07/2012 |
| Intramural, Investigation of Reduction of Blood Pressure and Metabolic Rate in Obese Hypertensive Patients Using Eplerenone:Implications for Treatment of Hypertension and Heart Failure | 11/2006 - 11/2008 |
| Extramural, A 10-Week, Multicenter, Randomized, Double-Blind, Parallel-Group, forced-Titration Study Using 24-Hour ABPM to Evaluate the Efficacy of a Valsartan/Hydrochlorothiazide (HCTZ) Treatment Regimen Versus Conventional Treatment Regimen with Amlodipine and Hydrochlorothiazide (HCTZ) in Patients with State 2 Hypertension, Novartis Pharmaceuticals | 11/2006 - 07/2008 |
| Extramural, A Multicenter, Randomized, Double-Blind, Active Controlled Study to Compare the Effect of 24 Weeks Treatment with Vildagliptin 100 mg qd or Metformin 1500 mg Daily in Elderly Drug Naive Patients with Type 2 Diabetes (LAF237A), Novartis Pharmaceuticals | 09/2006 - 08/2008 |
| Extramural, A 54-Week, Open Label, Multicenter Study to Assess the Long Term Safety and Combination of Aliskiren 300 mg/Valsartan 320 mg in Patients with Essential Hypertension, Novartis Pharmaceuticals | 07/2006 - 08/2008 |
| Extramural, Liraglutide Effect and Action in Diabetes: Effect on Glycemic Control of Laraglutide versus Glimepiride in Type 2 Diabetes. A 52 Week Double-Blind, Multicenter, Randomized, Parallel Study to Investigate Safety and Efficacy (LEAD), Abbott/Covance | 04/2006 - 04/2009 |
| Extramural, A Long-Term, Open-Label, Safety Extension Study of the Combination of Fenofibric Acid and Statin Therapy for Subjects with Mixed Dyslipidemia (M05-758), Novo Nordisk | 01/2006 - 12/2007 |
| Extramural, A Multicenter, Randomized, Double-Blind, Prospective Study Comparing the Safety and Efficacy of Fenofibric Acid and Atorvastatin Calcium Combination Therapy to Fenofibric Acid and Atorvastatin Calcium Monotherapy in Subjects with Mixed Dyslipidemia, Novo Nordisk | 01/2006 - 12/2007 |
| Extramural, A Double-Blind, Randomized, Placebo and Active Controlled Forced Titration Study Evaluating the Effects of Nebivolol on Blood Pressure and Heart Rate in African American Patients with Hypertension, Mylan/Bertek Pharmaceuticals | 04/2005 - 03/2007 |
| Extramural, Hypertension Education and Treatment (HEAT) Partnership, NIH/HNLBI | 09/2004 - 08/2009 |
| Extramural, Clinical Trial of Dietary Protein on Blood Pressure, NHLBI | 07/2004 - 06/2008 |
| Extramural, An 8-Week Double-Blind, Multicenter, Randomized, Multifactorial, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Aliskiren Administered Alone and in Combination with Hydrochlorothiazide in Patients with Essential Hypertension (“Study 100A”), Novartis Pharmaceuticals | 07/2004 - 02/2006 |
| Extramural, Clinical Utility of Caduet in Simultaneously Achieving Blood Pressure and Lipid Endpoints in a Specific Patient Population, Pfizer Pharmaceuticals | 05/2004 - 12/2005 |
| Extramural, A Prospective, Multinational, Multicenter, Double-Blind, Randomized, Active-Controlled Trial to Compare the Effects of Lotrel (amlodipine/benazepril) to Benazepril and Hydrochlorothiazide Combined on the Reduction of Cardiovascular Morbidity and Mortality in Patients with High Risk Hypertension, Novartis | 10/2003 - 06/2009 |
| Extramural, A Prospective, Multinational, Multicenter, Double-Blind, Randomized, Active-Controlled Trial to Compare the Effects of Lotrel to Benaepril and Hydrochlorothiazide Combined on the Reduction of Cardiovascular Morbidity and Mortality in Patients with High Risk Hypertension, Novartis Pharmaceuticals | 10/2003 - 06/2009 |
| Extramural, A Multi-Center, Randomized, Double-Blind, Double-Dummy Study Evaluating the Safety and Efficacy of the Addition of Amlodipine to Quinapril or Losartan in the Treatment of Diabetic Hypertensive Subjects, Pfizer Pharmaceuticals | 04/2003 - 03/2004 |
| Extramural, A Phase 3, Randomized, Triple-Blind, Parallel-Group, Long-Term, Placebo-Controlled, Multicenter Study to Examine the Effect on Glucose Control (HbA1c) of AC2993 Given Two Times a Day in Subjects with Type 2 Diabetes Mellitus Treated with Sulfonylurea Alone, Amylin Pharmaceuticals | 04/2003 - 12/2003 |
| Extramural, A Double-Blind, Randomized, Vehicle-Controlled Study Comparing the Safety and Efficacy of Benzydamine Hydrochloride 0.15% Oral Rinse Including a Separate Open-Label Standard of Care Arm in Subjects with Radiation-Induced Oral Mucositis, McNeil Consumer & Speciality Pharmaceuticals | 03/2003 - 03/2004 |
| Extramural, A Randomized, Double-Blind, Multicenter, Multifactorial, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy and Safety of Valsartan and Amlodipine Combined and Alone in Hypertensive Patients, Novartis Pharmaceuticals | 10/2002 - 10/2004 |
| Extramural, Dose Finding, Efficacy, and Safety of AZ 242 in Subjects with Type 2 Diabetes, Protocol 270, AstraZeneca | 08/2002 - 08/2003 |
| Extramural, Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of Cevimeline in the Treatment of Xerostomia Secondary to Radiation Therapy for Cancer in the Head and Neck Region, Daiichi Pharmaceutical Corporation | 08/2002 - 08/2003 |
| Extramural, Clinical Trial of Dietary Protein on Blood Pressure, National Institution of Health (NIH) | 07/2002 - 06/2003 |
| Extramural, A 6-week, Randomized, Open-Label, Comparative Study to Evaluate the Efficacy and Safety of Rosuvastatin and Atorvastatin in the Treatment of Hypercholesterolemia in African American Subjects, AstraZeneca | 06/2002 - 12/2003 |
| Extramural, A Phase 3, Randomized, Triple-Blind, Parallel-Group, Long-Term, Placebo-Controlled, Multicenter Study to Examine the Effect on Glucose Control (HbA1c) of AC2993 Given Two Times a Day in Subjects with Type 2 Diabetes Mellitus Treated with Metformin and a Sulfonylurea, Amylin Pharmaceuticals | 05/2002 - 02/2004 |
| Extramural, A Phase 3, Randomized, Triple-Blind, Parallel-Group, Long-Term, Placebo-Controlled, Multicenter Study to Examine the Effect on Glucose Control (HbA1c), of AC2993 Given Two Times a Day in Subjects with Type 2 Diabetes Mellitus Treated with Metformin Alone, Amylin Pharmaceuticals | 04/2002 - 12/2003 |
| Extramural, DioVan Antihypertensive Long-Term Use Evaluation: A Prospective, Multinational, Multicenter, Double-Blind, Randomized, Active-Controlled Trial in Patients with Essential Hypertension to Compare the Effect of Valsartan 80 and 160 mg, with or without the addition of hydrochlorothiazide, once daily to that of amlodipine 5 and 10 mg once daily, with or without the addition of hydrochlorothiazide, on cardiovascular morbidity and mortality (VALUE Study), Novartis Pharmaceuticals | 03/2002 - 03/2005 |
| Extramural, A Multicenter, Double-Blind, Randomized Study to Evaluate the Effects of Valsartan and the Combination of Valsartan and Simvastatin on Blood Pressure (Ambulatory and Standard Cuff) and on Selected Biochemical Markets of Endothelial Function, Safety and Tolerability (VAS Study), Novartis Pharmaceuticals | 03/2002 - 03/2003 |
| Extramural, A Randomized, Multicenter, Double-Blind, Parallel Group Study to Determine the Efficacy and Safety of Lotrel versus Enalapril in the Treatment of Hypertension in an African-American Population with Type 2 Diabetes (Lotrel Study), Novartis Pharmaceuticals | 02/2002 - 10/2003 |
| Extramural, A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of the Efficacy and Safety of Long Term Administration of Nateglinide and Valsartan in the Prevention of Diabetes and Cardiovascular Outcomes in Subjects with Impaired Glucose Tolerance (The Navigator Study), Novartis Pharmaceuticals | 12/2001 - 09/2010 |
| Extramural, A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of the Efficacy and Safety of Long Term Administration of Nateglinide and Valsartan in the Prevention of Diabetes and Cardiovascular Outcomes in Subjects with Impaired Glucose Tolerance (IGT)(The Navigator Study), Novartis Pharmaceuticals | 11/2001 - 09/2009 |
| Extramural, Pravastatin or Atorvastatin Evaluation and Infection Therapy (Prove It), Bristol-Myers Squibb | 09/2001 - 09/2004 |
| Extramural, Antihypertensive Efficacy of Adding Candesartan Cilexetil to Lisinopril in Comparison to Up-titration of Lisinopril (AMAZE), Astra Zeneca | 09/2001 - 09/2002 |
| Extramural, Genetics of Microangiographic Brain Injury; Sub-study on Ambulatory Blood Pressure Study. Sub-contractor under Mayo Clinic of Rochester, National Institutes of Health/National Institute of Neurological Disorders and Stroke | 05/2001 - 05/2006 |
| Extramural, Multicenter, Randomized, Double-Blind, Placebo-Controlled and Open-Label Evaluation of the Safety and Efficacy of Dual therapy with Atorvastatin Plus Amlodipine When Compared to Either Therapy Alone in the Treatment of Patients with Simultaneous Hyperlipidemia and Hypertension (The AVALON Study), Pfizer Pharmaceuticals | 05/2001 - 07/2003 |
| Extramural, Omapatrilat in Persons with Enhanced Risk of Atherosclerotic Events (OPERA) (CV137-056), Bristol-Myers Squibb | 12/2000 - 12/2005 |
| Extramural, A Multicenter, Randomized, Double-Blind, Active Control Trial to Evaluate the Safety and Efficacy of Metformin/Glyburide Tablets as First Line Therapy in Patients with Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control with Diet and Exercise (CV138-054), Bristol-Myers Squibb | 07/2000 - 03/2001 |
| Extramural, A Multicenter, Randomized, Double-Blind, Parallel Group Trial Comparing the Safety and Efficacy of Metformin/Glyburide to Pioglitazone as First Line Therapy in Patients with Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control with Diet and Exercise (CV138-056), Bristol-Myers Squibb | 06/2000 - 03/2001 |
| Extramural, Clinical Protocol for a Double-Blind, Randomized, Placebo and Active-Controlled Comparison Study of the Antihypertensive Effect and Safety of Eplerenone Versus Placebo and Versus Losartan in Black and White Hypertensive Patients (020), G. D. Searle | 11/1999 - 12/2000 |
| Extramural, A Double-Blind, Randomized Study Comparing the Effects of a Modified-Release Formulation of Pravastatin with Placebo and with Atorvastatin in Patients with Hypercholesterolemia, Bristol-Myers Squibb | 09/1999 - 08/2001 |
| Extramural, Candesartan Cilexetil in Heart Failure Assessment of Reduction in Mortality and Morbidity (CHARM), AstraZeneca | 08/1999 - 07/2003 |
| Extramural, Evaluation of the Antihypertensive Efficacy of Candesartan Cilexetil in Comparison to Losartan: A Multicenter, Double-Blind, Randomized, Parallel-Group, Forced-Titration Study (CLAIM), AstraZeneca | 08/1999 - 02/2000 |
| Extramural, Clinical Protocol for a Double-Blind, Controlled, Randomized Comparison of Eplerenone and Losartan in Patients with Low Renin Hypertension (019), G. D. Searle | 07/1999 - 07/2000 |
| Extramural, Clinical Protocol for a Double-Blind, Controlled, Randomized Comparison Study of the Antihypertensive Effect of Eplerenone and Spironolactone in Patients with Hypertension Secondary to Primary Aldosteronism (018), G. D. Searle | 07/1999 - 07/2000 |
| Extramural, A Randomized, Double-Blind, Amlodipine-and Losartan-Controlled Study of Omapatrilat in Subjects with Mild to Moderate Hypertension, Bristol-Myers Squibb | 03/1999 - 01/2000 |
| Extramural, Jackson Heart Study (Examination Center), NIH/NHLBI | 01/1999 - 12/2005 |
| Extramural, Controlled Onset Verapamil Investigation of Cardiovascular Endpoints (CONVINCE Study), G. D. Searle | 07/1998 - 09/2003 |
| Extramural, A Randomized, Double-Blind, Placebo-Controlled, Multicenter, Long-Term Trial of Preventing Hypertension Using Candesartan Cilexetil 16mg in Patients with High Normal Blood Pressure (TROPHY), AstraZeneca | 03/1998 - 03/2004 |
| Extramural, ABC Study of Hypertension: Efficacy of Candesartan Cilexetil in Hypertensive Black Patients, Astra-Merck | 01/1998 - 12/1999 |
| Extramural, Jackson Heart Study (Feasibility Phase), NIH/NHLBI | 10/1997 - 09/1999 |
| Extramural, Mississippi Hypertension Disease Management Network, Merck & Co., Inc | 01/1997 - 12/1998 |
| Intramural, Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT), NIH/NHLBI- University of Texas | 09/1994 - 08/2001 |
Publications
Article | |
| Jiang He, Marion R. Wofford, Kristi Reynolds, Jing Chen, Chung-Shiuan Chen, Leann Meyers, Deborah L. Minor, Patricia J. Elmer, Daniel W. Jones and Paul K. Whelton Effect of Dietary Protein Supplementation on Blood Pressure: A Randomized Control Trial Circulation A Journal of the American Heart Association | 2011 |
Journal Article | |
| Riche DM, Riche KD, Blackshear CT, McEwen CL, Sherman JJ, Wofford MR, Griswold ME. Pterostilbene on metabolic parameters: a randomized, double-blind, and placebo-controlled trial. Evid Based Complement Alternat Med. 2014;2014:459165. doi: 10.1155/2014/459165. Epub 2014 Jun 25. | 2014 |
| Riche DM,Wilson L,Jackson RT,Wofford MR,Adams C. Effect on institutional revenue of clinical pharmacy services in an ambulatory care clinic. Am J Health Syst Pharm.2013 Mar 15;70(6):482,484. | 2013 |
| Riche DM, McEwen CL,Riche KD,Sherman JJ,Wofford MR,Deschamp D,Griswold M. Analysis of safety from a human clinical trial with pterostilbene. J Toxicol. 2013;2013. | 2013 |
| Malinowski SS, Byrd JS, Bell AM, Wofford, MR, Riche DM Pharmacologic Therapy For Nonalcoholic Fatty Liver Disease in Adults. Pharmacotherapy.2013 Feb;33(2):223-42. dio: 10.1002/phar.1190.Epub 2013 Jan 28 | 2013 |
| Rebholz CM, Reynolds K, Wofford MR, Chen J, Kelly TN, Mei H, Whelton PK, He J. Effect of Soybean Protein on Novel Cardiovascular Disease Risk Factors: A randomized controlled trial. Eur J Clin Nutr. 2013 Jan; 67 (1):58-63. doi: 10.1038/ejcn.2012.186. Epub 2012 Nov 28 | 2012 |
| Call RJ, Wofford MR, Riche DM Top 10 Facts You Should Know About Diabetes J Miss State med Assoc. 2012 Aug:53(8):275-7. | 2012 |
| Roberta Lima & Marion Wofford & Jane F. Reckelhoff Hypertension in Postmenopausal Women Curr Hypertens Rep 14(3): 254-60, June 2012. | 2012 |
| Lima R, Wofford, MR, Reckelhoff JF Lima R, Wofford, MR, Reckelhoff JF. Hypertension in Postmenopausal Women. Current Hypertens Rep. 2012 Mar 17. Current Hypertens Rep. 2012 Mar 17. | 2012 |
| Wyatt SB, Akylbekova EL, Wofford MR, Coady SA, Walker ER, Andrew ME, Keahey Wj, Taylor HA, Jones DW Prevalence, Awareness, Treatment, and Control of Hypertension in the Jackson Heart Study Hypertension, 2008;Mar;51(3):650-6 | 2008 |
| Long RC, wofford MR, Harkins KG, Minor DS Hepatocellular Necrosis Associated With Labetalol J Clin Hypertens, 2007;Apr;9(4):287-90 | 2007 |
| Currier M, King DS, Wofford MR, Daniel BJ, Deshazo R A Katrina experience: lessons learned Am J Med. 2006 Nov; 119 (11):986-92 | 2006 |
| Wofford MR, King DS, Harrell TK Drug-Induced Metabolic Syndrome J Clin Hypertens 2006; 8:114-119 | 2006 |
| Mellen PB, Bleyer AJ, Erlinger RP, Evans GW, Nieto FJ, Wagenknecty LE, Wofford MR, Herrington DM Serum Uric Acid Predicts Incident Hypertension in a Biethnic Cohort The Atherosclerosis Risk in Communities Study. Hypertension. 2006 Dec;48(6):1037-42. Epub 2006 Oct. 23 | 2006 |
| Brock CC, King DS, Wofford MR, Harrell TK Exercise, Insulin Resistance, and Hypertension: A Complex Relationship Metabolic Syndrome and Related Disorders. Mar 2005, Vol. 3, No. 1: 60-65 | 2005 |
| Egan BM, Papademetriou V, Wofford M, Calhoun D, Fernandes J, Riehle JE, Nesbitt S, Michelson E, Julius S, for the Trophy Sub-study Investigated Team Metabolic Syndrome and insulin resistance in the Trophy sub-study: contrasting views in patients with high-normal blood pressure Am J Hypertens 2005; 18:3-12 | 2005 |
| Wofford,MR, King DS Relationship Between Antihypertensive Drugs and Metabolic Syndrome Metabolic Syndrome and Related Disorders. 2004;2(4):308-314 | 2004 |
| Wilburn AM, King DS, Gisson J, Rockhold RW, Wofford MR Natural Treatment of Hypertension J Clin Hypertens. 2004;6:242-248 | 2004 |
| Hall JE, Crook ED, Jones DW, Wofford MR, Dubbert PM Mechanisms of Obesity-Associated Cardiovascular and Renal Disease Am J Med Sci 2002 Sep;324(3):127-37 | 2002 |
| Andrew ME, Jones DW, Schreiner PJ, Wofford MR, Wyatt SB, Brown CA, Young DB, Taylor HA Ethnicity and Unprovoked Hypokalemia in the Atherosclerosis Risk in Communities Study Am J Hypertens 2002;15:594-599 | 2002 |
| Bakris G, Gradman A, Reif M, Wofford M, Munger M, Harris S, Vendetti J, Michelson E, Wang R Antihypertensive Efficacy of Candesartan in Comparison to Losartan: The Claim Study J Clin Hypertens. 2001;3:16-21 | 2001 |
| Wong TY, Klein R, Couper D, Cooper L, Shahar E, Hubbard L, Wofford MR, Sharrett AR Retinal Microvascular Abnormalities and Incident Strokes: The Atherosclerosis Risk in Communities Study Lancet 2001;358:1134-40 | 2001 |
| King DS, Jones DW, Wofford MR, Harkins KG, Harrell TK, Kelly KW Cognitive Impairment Associated with Atorvastatin Pharmacotherapy 2001;21(3):36 | 2001 |
| King DS, Noble SL, Harrell TK, Wofford MR Education, Service, and Pharmaceutical Care Opportunities for Pharmacy Students Through Medical Missions Pharmacotherapy 2001;21(3):107 | 2001 |
| Wofford MR, Anderson DC, Brown CA, Jones DW, Miller ME, Hall JE Antihypertensive Effect of - and - Adrenergic Blockade in Obese and Lean Hypertensive Subjects Am J Hypertens 2001;14:694-698 | 2001 |
| Gress TW, Nieto FJ, Shahar E, Wofford MR, Brancati FL Antihypertensive Therapy and the Risk of Type 2 Diabetes Mellitus: The Atherosclerosis Risk in Communities (ARIC) Study N Engl J Med. 2000;342:905-12 | 2000 |
| King DS, Wofford MR Obesity and Hypertension Drug Topics. 1999;144(1):59-68 | 1999 |
| Wofford MR, Andrew ME, Pickett RA, Brown CA, Wyatt S, King D, Jones DW Obesity Hypertension in the Atheroslerosis Risk in Communities Cohort: Implications of Obesity Guidelines J Clin Hypertens. 1999;1:27-32 | 1999 |
| Jones DW, Miller ME, Wofford MR, Anderson DC, Cameron ME, Willoughby DL, Adair CT, King NS The Effect of Weight Loss Intervention on Antihypertensive Medication Requirements in the Hypertension Optimal Treatment (HOT) Study Am J Hypertens. 1999;12:1175-1180 | 1999 |
| Robbins MA, Stewart RN, Wofford MR Clinicopathologic Conference XXI. Case Records of the Department of Medicine University of Mississippi Medical Center. Journal of the Mississippi State Medical Association. 1998 | 1998 |
| Riche DM,Fleming JW,Malinowski SS,Black CA, Miller KH, Wofford MR. Resistant nonalcoholic fatty liver disease amelioration with rosuvastatin and pioglitazone combination therapy in a patient with metabolic syndrome. Ann Pharmacother. 2014 Jan; 48 (1):137-41. | |
Review Article | |
| Sucher BJ, King DS, Wofford MR Practical Management of Obesity Drug Topics 2002;146:9: 82-91 | 2002 |
| King DS, Wofford MR, Stewart JL The renin-angiotensin system: A primary target for cardiovascular disease prevention Drug Topics 2002 Nov. 146(21):64-73 | 2002 |
| Wofford MR, King DS, Wyatt SB, Jones DW Secondary Hypertension: Detection and Management for the Primary Care Provider J Clin Hypertens. 2000;2:124-131 | 2000 |
| King DS, Wofford MR Identification/Management of Obstructive Sleep Apnea Drug Topics. 2000;144(15):41-50 | 2000 |
| King DS, Wofford MR Obesity and Diabetes Mellitus Drug Topics. 1999;144(2):69-78 | 1999 |
Abstracts | |
| Minor D, Butler K, Wofford M Blood pressure control rates among patients with chronic kidney disease or diabetes in a hypertension referral clinic Proceedings of the ASHP 2010 Summer Meeting and Exhibition: An Intensive Educational and Skills-Building Experience for Health-System Pharmacy Leaders, Tampa, FL. June 7, 2010:43 | 2010 |
| Long RC, King DS, Wofford MR, Harkins KG, Stewart JL Hepatocellular Necrosis Associated with Labetalol Am J Hypertens 2005 May 18(5 Pt 2):67A | 2005 |
| Wofford MR, KIng DS, Harkins KG, Stewart JL, Noble SL, Usery JB, Shimozono T Incidence of Hyperkalemia Associated with Aldosterone Antagonists in a Hypetension Referral Center Am J Hypertens 2005 May 18(5Pt 2):76A | 2005 |
| Rice SD, King DS, Harrell TK, Stewart JL, Wofford MR Hypertension Awareness, Control and Treatment in Rural Mississippi: Morton Have-A-Heart Project Am J Hypertens 2005 May 18(5 Pt 2):149A | 2005 |
| Stewart JL, Harkins K, King D, Wofford M The Effects of Extended Duty Hours on Ambulatory Blood Pressures in Internal Medicine, Pediatric, and Med-Peds Residents Am J Hypertens 2004 May 17 (5 Pt 2):57A | 2004 |
| King DS, Barud SJ, Wofford MR, Noble SL, Fontenot TM, Reed RR, Harkins KG, Stewart JL, Wyatt SB, McDaniel A Improving Medication Adherence in a Southeastern Hypertension Clinic Using Adhererx Am J Hypertens 2004 May 17(5 Pt 2):222A | 2004 |
| Reed RR, King DS, Wofford MR, Adair CM, Harkins KG, Stewart JL, Wyatt SB, Harrell TK Variations in Blood Pressure Control Throughout the Dosing Interval with Morning Versus Evening Dosing of Once-Daily Antihypertensive Medications Am J Hypertens 2004 May 17(5 Pt 2):121A | 2004 |
| Barud SJ, King DS, Reed RR, Harkins KG, Wofford MR, Noble SL Screening for Depression and Anxiety in a Hypertension Specialty Clinic Am J Hypertens 2004 May 17(5 Pt 2):224A | 2004 |
| Stewart JL, King DS, Harrell TK, Davy BM, Wofford MR, Noble SL Increasing awareness, detection, and management of cardiovascular risk factors in children and adolescents Am J Hypertens 2003 May;16(5 Pt 2):249A | 2003 |
| King DS, Thomas JR, Habeeb GE, Harkins KG, Harrell TK, Noble SL, Stewart JL, Wofford MR, Wyatt SB, Smith M, Owens B Medication adherence in a southeastern hypertension clinic Am J Hypertens 2003 May;16(5 Pt 2):234A | 2003 |
| King DS, Stewart JL, Cloy JA, Noble SL, Wofford MR, Samuel J, Aiello M, Tonore TB Addressing pediatric hypertension in residency training programs Am J Hypertens 2003 May;16(5 Pt 2):237A | 2003 |
| Habeeb GE, Wofford MR, King DS, Wood RL, Noble SL A rare case of labetalol induced hepatic necrosis Am J Hypertens 2003 May;16(5 Pt 2):117A-118A | 2003 |
| Thomas JR, King DS, Wofford MR, Habeeb, GE, Harkins KG, Stewart JL, Wyatt SB, Noble SL Strategies for increasing influenza vaccination rates among a high-risk cardiovascular population Am J Hypertens 2003 May;16(5 Pt 2):235A | 2003 |
| Wofford MR, Davis MM, Harkins KG, King DS, Warnock JL, Wyatt SB, Jones DW Screening for Primary Aldosteronism in Hypertensive Patients Am J Hypertension 2000;13(4)Part 2: 8A-9A | 2003 |
| Wofford MR, King DS, Habeeb GE, Harkins KG, Stewart JL, Wyatt SB Long-term management of hypertensive patients with primary aldosteronism Am J Hypertens 2003 May;16(5 Pt 2):256A | 2003 |
| Harrell TK, Horton NN, King DS, Wofford MR Assessment of cardiovascular risk factor awareness and accentuation of early detection among African-American college students Am J Hypertens 2003 May;16(5 Pt 2):244A-245A | 2003 |
| Harkins KG, King DS, Habeeb GE, Stewart JL, Wyatt SB, Wofford MR Use of a long-acting loop diuretic to improve blood pressure control Am J Hypertens 2003 May;16(5 Pt 2):118A | 2003 |
| Wofford MR, Harkins KG, King DS, Habeeb GE, Wyatt SB, Jones DW Accurate Cuff Size in Blood Pressure Measurement American Journal of Hypertension 2002:15(4) Part 2;92A | 2002 |
| King DS, Noble SL, Wyatt SB, Wofford MR, Harrell TK, Walker ER A Statewide Campaign for Increasing Health Awareness: Know Your Numbers American Journal of Hypertension 2002:15(4) Part 2;224A | 2002 |
| King DS, Wofford MR, Harrell TK, Noble SL Blood pressure measurement: selection of appropriate cuff size for office and home monitoring Pharmacotherapy 2002:22(10)1333 | 2002 |
| Wyatt SB, Harkins KG, King DS, Wofford MR, Jones DW Invoking Source of Spiritual Sustenance as a Treatment Strategy in African Americans with Hypertension American Journal of Hypertension 2002:15(4) Part 2;145A | 2002 |
| King DS, Wofford MR, Wyatt SB, Habeeb GE, Harkins KG, Harrell TK, Jones DW, Sucher B, Noble SL Assessing Health Awareness in Patients with Hypertension American Journal of Hypertension 2002:15(4) Part 2;223-224A | 2002 |
| Harrell TK, King DS, Crenshaw HT, Wofford MR, Jones DW Incorporation of a cardiovascular risk factor awareness program in the core curriculum of a rural Mississippi high school Pharmacotherapy 2002:22(10)1375 | 2002 |
| Harrell TK, Wofford MR, Wyatt SB, Jones DW The Morton Have-A-Heart Project: Evaluation of Elevated Blood Pressures, Total Cholesterol Levels, and Glucose Levels in a Rural Mississippi Community American Journal of Hypertension 2002:15(4) Part 2;224A | 2002 |
| King DS, Wofford MR, Harrell TK, Noble SL Utilizing a self-administered health awareness questionnaire to increase clinic educational efforts Pharmacotherapy 2002:22(10)1336 | 2002 |
| Egan B, Wofford M, Calhoun D, Nesbitt S, Cohn J, Julius S Leptin is Associated with Insulin Resistance and Impaired Small Artery Distensibility in Subjects with High Normal Blood Pressure American Journal of Hypertension 2002:15(4) Part 2;221-222A | 2002 |
| Horton NN, Harrell TK, King DS, Wofford MR, Low AK, Noble SL Assessment of Awareness of Obesity and Blood Pressure as Cardiovascular Risk Factors in African-American College Students Obesity Research 2001:9(3)163S | 2001 |
| Walters LA, Hallam J,Wofford MR, King DS, Loyd S A Tale of Two Cardiovascular Health Planning Groups Preventive Medicine 2001:33(2)S18 | 2001 |
| King DS, Jones DW, Wofford MR, Wyatt SB, Tidwell BH, Harkins KG, Harrell TK Pilot Project for Reduction of Cardiovascular Disease in Mississippi Rural Communities Am J Hypertension 2001;14(4)Part 2:247A | 2001 |
| Wofford MR, King DS, Wyatt SB, Harkins KG, Kelly KW, Jones DW Screening for Obstructive Sleep Apnea (OSA) in Patients with Hypertension Am J Hypertension 2001;14(4)Part 2:255A | 2001 |
| Harrell TK, King DS, Wofford MR, Wyatt SB, Jones DW Selection of a Rural Community Site for a Comprehensive Enabling Cardiovascular Disease Risk Reduction Intervention Preventive Medicine 2001:33(2)S14 | 2001 |
| King DS, Kelley KW, Wyatt SB, Wofford MR, Harkins KG, Jones DW Utility of Ambulatory Blood Pressure Monitoring in a Hypertension Specialty Clinic Am J Hypertension 2001;14(4)Part 2:49A | 2001 |
| Harrell TK, Horton NN, King DS, Wofford MR, Low AK, Noble SL Assessment of the Awareness of Obesity and Blood Pressure as Cardiovascular Risk Factors in a Historically African-American University Pharmacotherapy 2001:21(10)1262 | 2001 |
| Wofford MR, Harkins KG, King DS, Wyatt SB, Jones DW Screening for Primary Aldosterone in Older Patients with Hypertension Am J Hypertension 2001;14(4)Part 2:253A | 2001 |
| Wofford MR, Harrell TK, King DS, Stewart JL The Morton Have-A-Heart Adolescent Obesity Project: A School-Based Program to Heighten Awareness Among Medicine-Pediatric Residents Preventive Medicine 2001;33(2):35 | 2001 |
| Harkins KG, King DS, Wofford MR, Wyatt SB, Jones DW Iatrogenic Hypotension Associated with Normal-Tension Glaucoma Am J Hypertension 2001;14(4)Part 2:46A | 2001 |
| Wyatt SB, Harkins KG, King DS, Wofford MR, Jones DW Prevalence of Secondary Hypertension in a Southeastern US Hypertension Referral Center Am J Hypertension 2001;14(4)Part 2:253A | 2001 |
| Kelley KW, King DS, Wofford MR, Wyatt SB, Jones DW The Use of Ambulatory Blood Pressure Monitoring to Influence Drug Regimens in a Hypertension Specialty Clinic Pharmacotherapy 2001:21(10)1261-2 | 2001 |
| Brown A, Andrew M, Clemons T, King D, Taylor H, Wofford M, Wyatt S, Jones D Classification of JNC VI Blood Pressure Stages and Risk Groups in the ARIC Study Am J Hypertension 2000;13(4)Part 2:270A | 2000 |
| King DS, Noble SL, Harkins KG, Wofford MR, Harrell TK, Ramsey LA, Replogle WH, Tidwell BH Evaluation of Compliance with National Cholesterol Education Program Recommendations for Screening and Treatment of Hyperlipidemia in Medical Resident Primary Care Training Clinics Pharmacotherapy 2000;20(10):1235 | 2000 |
| Harkins KG, King DS, Wofford MR, Brown CA, Wyatt SB, Miller-Davis ME, Ramsey LA, Jones DW Screening for Dyslipidemia in Resident Training Clinics: Is Cardiovascular Risk Management Adequate Am J Hypertension 2000;13(4)Part 2:101A | 2000 |
| Wofford MR, Andrew ME, King DS, Stevens J, Wyatt SB, Jones DW Implications of Obesity Guidelines to the Atherosclerosis Risk in Communities Cohort Ethnicity & Disease. 2000;10(2):292-293 | 2000 |
| Harrell TK, Horton NN, King DS, Wofford MR, Low AK, Noble SL Women=s Health Initiative of Mississippi: An Innovative Approach to Promoting Wellness Obesity Research 2000;8(1):104S | 2000 |
| King DS, Wyatt SB, King NS, Wofford MR, Statham LH, Pearson MM, Harrell TK, Jones DW Improvement in Blood Pressure Control Through Interdisciplinary Medication Assistance Efforts in Hypertensive Patients with Multiple Metabolic Syndrome Am J Hypertension 2000;13(4)Part 2:18A | 2000 |
| Wofford MR, Davis MM, Harkins KG, King DS, Warnock JL, Wyatt SB, Jones DW Screening for Primary Aldosteronism in Hypertensive Patients Am J Hypertension 2000;13(4)Part 2: 8A-9A | 2000 |
| King DS, Wyatt SB, Wofford MR, Harrell TK, Jones DW Improvement in Blood Pressure Control Through Interdisciplinary Medication Assistance Efforts in Hypertensive Patients with Multiple Metabolic Syndrome Pharmacotherapy 2000;20(10):1235 | 2000 |
| Wofford MR, Adair C, Anderson DC, Hall JE, Miller ME, Jones DW Alpha and Beta Blockade in Obese and Lean Hypertensive Subjects Hypertension. 1998;32(3);595 | 1998 |
| Wofford MR, Miller ME, Cameron ME, Willoughby DL, Adair CM, Jones DW Effects of Weight Loss Intervention in HOT Weight Loss Substudy Participants Am J Hypertension. 1997;10(4)Part 2:84A | 1997 |
| Jones DW, Miller ME, Wofford MR, Anderson DC, Cameron ME, Willoughby DL, Adair CM, King NS The Effect of Weight Loss Intervention on Antihypertensive Medication Requirements in the Hypertension Optimal Treatment (HOT) Study Hypertension. 1997;30(3):486 | 1997 |
Book Chapter | |
| Recekelhoff J, Wofford MR Hypertension In Women Women & Health, Second Edition. Goldman MB, Troisi R, Rexrode KM (ed): Elsovier Inc., 2013,pp 1069-1079. | 2013 |
| Riche, D.M.,Wilson, L.,Terry Jackson R.,Wofford, M.R.,Adams C. Effect on Institutional Revenue of Clinical Pharmacy Services in an Ambulatory Care Clinic Americal Journal of Health-System Pharmacy | 2013 |
| Riche, D.M., McEwen, C.L.,Riche, K.D.,Sherman, J.J.,Wofford, M.R., Deschamp, D., Griswold, M. Analysis of Safety from a Human Clinical Trial with Pterostilbene Journal of Toxicology | 2013 |
| Stewart JL,Wofford MR Metabolic Syndrome Pharmacotherapy in Primary Care , McGray-Hill;New York City,pp 293-297 | 2008 |
| Wofford MR, Hall JE Pathophysiology and Treatment of Obesity Hypertension Current Pharmaceutical Design. 2004;10:3621-3637 | 2004 |
| Jones DW, Wofford MR Intervention in Minorities Whelton PK, HE J, Louis GT (ed): Lifestyle Modification for the Prevention and Treatment of Hypertension: New York, Marcel Dekker, Inc., 2003, pp365-378 | 2003 |
| Wofford MR Primary Aldosteronism In Egan BM, Basile JN, Lackland DT: Hypertension Hot Topics: Philadelphia, Hanley & Belfus, Inc., 2003, pp 99-104 | 2003 |
| Wofford MR, Jones DW Pheochromocytoma: Detection and Management In: Hypertension:A Companion to Brenner and Rector’s The Kidney. Oparil, S, Weber, M, eds. Philadelphia: Elsevier Saunders, pp. 807-812 | |
Book | |
| Linn WD, Wofford MR, O'Keefe ME, Posey ML Pharmacotherapy in Primary Care McGraw-Hill;New York City, 2008 | 2008 |
| Jones DW, King DS, Wofford MR Hypertension Pearls Philadelphia, Hanley & Belfus, Inc. 2004 | 2004 |
Presentations
| Invited Symposia, Approach to the Patient with Resistant Hypertension, Cardiovascular Disease Symposium, Jackson, MS | 04/2013 |
| Regional Invited Seminars/Lectures, Cardiovascular Health, Advanced Practice Providers, Jackson, MS | 03/2013 |
| State/Local Invited Seminars/Lectures, Update in Resistant Hypertension, Advanced Practice Provider Conference, Jackson, MS | 02/2013 |
| Invited Symposia, Update in Resistant Hypertension, Southern Society of General Internal Medicine, New Orleans, Louisiana | 02/2013 |
| Regional Invited Seminars/Lectures, Updates in Hypertension Management., Southern SGIM 2013 Regional Meeting, New Orleans, LA | 02/2013 |
| Clinical Hypertension Review Course, American Society of Hypertension, Jackson, MS | 04/2012 |
| Faculty Lectures on Renal Mechanism, Jackson, MS | 04/2012 |
| Hypertension in Children and Adolescents, Faculty Lecture, Jackson, MS | 04/2012 |
| Hypertension In Elderly, Faculty Lecture, Jackson, MS | 04/2012 |
| Hypertension in Pregnancy, Faculty Lecture, Jackson, MS | 04/2012 |
| Hypertensive Renal Disease, Jackson, Ms | 04/2012 |
| Office and Out-of-Office Blood Pressure Measurement, Jackson, MS | 04/2012 |
| Regional Invited Seminars/Lectures, Hypertension Treatment in Primary Care: Primary Care Symposium, Consortium for Southeastern Hypertension Control, Jackson, MS | 10/2010 |
| Poster Presentation, Assessment of 24-Hour Blood Pressure Effects: Metoprolol versus Nebivolol, American Society of Health-System Pharmacists Midyear Meeting, Orlando, Florida | 12/2008 |
| Poster Presentation, Prevalence of Resistant Hypertension in a Hypertension Clinic at a Large Academic Medical Center, American Society of Health-System Pharmacists Midyear Meeting, Orlando, Florida | 12/2008 |
| Poster Presentation, Evaluation of Hyperkalemia and the Use of Aldosterone Antagonists in Resistant and Secondary Hypertension in a Hypertension Referral Center and Family Medicine Practice, American Society of Health-System Pharmacists Midyear Meeting, Orlando, Florida | 12/2008 |
| Poster Presentation, Metabolic and Cardiac Changes in Obese Hypertensive Patients Using Eplerenone, American Society of Health-System Pharmacists Midyear Meeting, Orlando, Florida | 12/2008 |
| Regional Invited Seminars/Lectures, Treatment of Hypertension in Pregnancy. Hypertension in Obesity, Southern Medical Association 9th Annual Conference on Hypertension Improving Outcomes: A Case-Oriented Approach, New Orleans, LA | 06/2005 |
| Poster Presentation, Incidence of Hyperkalemia Associated with Aldosterone Antagonists in a Hypertension Referral Center, American Society of Hypertension 20th Annual Scientific Meeting, San Francisco, CA | 05/2005 |
| Regional Invited Seminars/Lectures, Treatment of Hypertension in Pregnancy, American Society of Hypertension Gulf Coast Regional Chapter, New Orleans, LA | 2005 |
| State/Local Invited Seminars/Lectures, Hypertension in Pediatrics and Adolescents, Mississippi Association of Public Health Physicians, Jackson, MS | 12/2004 |
| State/Local Invited Seminars/Lectures, Metabolic Syndrome: An Ounce of Prevention is Worth a Pound of Cure, Mississippi Society of Hospital Pharmacists, Philadelphia, MS | 07/2004 |
| State/Local Invited Seminars/Lectures, Hypertension in Adolescents, American Academy of Pediatrics Mississippi Chapter, Jackson, MS | 05/2004 |
| Poster Presentation, Improving Medication Adherence in a Southeastern Hypertension Clinic Using Adhererx., American Society of Hypertension 19th Annual Scientific Meeting, New York, NY | 05/2004 |
| State/Local Invited Seminars/Lectures, Isolated Systolic Hypertension, Information Quality Healthcare, Jackson, MS | 05/2004 |
| Poster Presentation, Screening for Depression and Anxiety in a Hypertension Specialty Clinic, American Society of Hypertension 19th Annual Scientific Meeting, New York, NY | 05/2004 |
| Poster Presentation, The Effects of Extended Duty Hours on Ambulatory Blood Pressures in Internal Medicine, Pediatric, and Med-Peds Residents, American Society of Hypertension 19th Annual Scientific Meeting, New York, NY | 05/2004 |
| Poster Presentation, Variations in Blood Pressure Control Throughout the Dosing Interval with Morning Versus Evening Dosing of Once-Daily Antihypertensive Medications, American Society of Hypertension 19th Annual Scientific Meeting, New York, NY | 05/2004 |
| State/Local Invited Seminars/Lectures, Hypertension in Adolescents, Mississippi State Department of Health, Primary Care Symposium, Jackson, MS | 02/2004 |
| Regional Invited Seminars/Lectures, Hypertension and Hyperlipidemia: Are We Treating the Same Disease?, American Society of Hypertension Gulf Coast Regional Chapter, New Orleans, LA | 2004 |
| State/Local Invited Seminars/Lectures, Hypertension: Management and Prevention, Mississippi Association of Public Health Physicians, Jackson, Mississippi | 12/2003 |
| Poster Presentation, A rare case of labetalol induced hepatic necrosis, American Society of Hypertension 18th Annual Scientific Meeting, New York, NY | 05/2003 |
| Poster Presentation, Addressing pediatric hypertension in residency training programs, American Society of Hypertension 18th Annual Scientific Meeting, New York, NY | 05/2003 |
| Poster Presentation, Assessment of cardiovascular risk factor awareness and accentuation of early detection among African-American college students, American Society of Hypertension 18th Annual Scientific Meeting, New York, NY | 05/2003 |
| Poster Presentation, Increasing awareness, detection, and management of cardiovascular risk factors in children and adolescents, American Society of Hypertension 18th Annual Scientific Meeting, New York, NY | 05/2003 |
| Poster Presentation, Long-term management of hypertensive patients with primary aldosteronism, American Society of Hypertension 18th Annual Scientific Meeting, New York, NY | 05/2003 |
| Poster Presentation, Medication adherence in a southeastern hypertension clin, American Society of Hypertension 18th Annual Scientific Meeting, New York, NY | 05/2003 |
| Poster Presentation, Strategies for increasing influenza vaccination rates among a high-risk cardiovascular population, American Society of Hypertension 18th Annual Scientific Meeting, New York, NY | 05/2003 |
| Poster Presentation, Use of a long-acting loop diuretic to improve blood pressure control, American Society of Hypertension 18th Annual Scientific Meeting | 05/2003 |
| State/Local Invited Seminars/Lectures, Hypertension Update, University of Mississippi Dental School - Dean’s Professional Development Lecture Series, Jackson, MS | 04/2003 |
| State/Local Invited Seminars/Lectures, ALLHAT: Implications to Clinical Care, University of Mississippi Medical Center, Jackson, MS | 04/2003 |
| State/Local Invited Seminars/Lectures, Hypertension Treatment: Attention to Targets, University of Mississippi Medical Center, Department of Medicine’s First Gathering of Alumni and Friends, Jackson, MS | 03/2003 |
| Poster Presentation, Incorporation of a cardiovascular risk factor awareness program in the core curriculum of a rural Mississippi high school, American College of Clinical Pharmacy 2002 Annual Meeting, Albuquerque, NM | 10/2002 |
| Poster Presentation, Utilizing a self-administered health awareness questionnaire to increase clinic educational efforts, American College of Clinical Pharmacy 2002 Annual Meeting, Albuquerque, NM | 10/2002 |
| Poster Presentation, Blood pressure measurement: selection of appropriate cuff size for office and home monitoring, American College of Clinical Pharmacy 2002 Annual Meeting, Albuquerque, NM | 09/2002 |
| State/Local Invited Seminars/Lectures, The Renin-Angiotensin System: A Primary Target for Cardiovascular Disease Prevention, University of Mississippi Department of Medicine Grand Rounds, Jackson, MS | 09/2002 |
| State/Local Invited Seminars/Lectures, Ensuring Optimal Therapy in the Primary Care Setting - Hypertension Management, Diabetes Update, Lipids 2002, Mississippi Academy of Family Practice Annual Meeting, Destin, FL | 07/2002 |
| Poster Presentation, A Statewide Campaign for Increasing Health Awareness: Know Your Numbers, American Society of Hypertension 17th Annual Scientific Meeting, New York, NY | 05/2002 |
| Poster Presentation, Accurate Cuff Size in Blood Pressure Measurement, American Society of Hypertension 17th Annual Scientific Meeting, New York, NY | 05/2002 |
| Poster Presentation, Assessing Health Awareness in Patients with Hypertension, American Society of Hypertension 17th Annual Scientific Meeting, New York, NY | 05/2002 |
| Poster Presentation, Invoking Source of Spiritual Sustenance as a Treatment Strategy in African Americans with Hypertension, American Society of Hypertension 17th Annual Scientific Meeting, New York, NY | 05/2002 |
| The Morton Have-A-Heart Project: Evaluation of Elevated Blood Pressures, Total Cholesterol Levels, and Glucose Levels in a Rural Mississippi Community, American Society of Hypertension 17th Annual Scientific Meeting, New York, NY | 05/2002 |
| State/Local Invited Seminars/Lectures, Hypertension Emergencies: Assessment and Management, Mississippi Access for Rural Care=s Clinical Conference, Hattiesburg, MS | 02/2002 |
| State/Local Invited Seminars/Lectures, Hypertension in the Elderly: Foscus on Systolic Blood Pressure, Greenwood Leflore Hospital, Greenwood, MS | 02/2002 |
| National and International Invited Seminars/Lectures, Obesity and It’s Effects in Comorbid Conditions, American Society of Health-Systems Pharmacists Midyear Clinical Meeting in New Orleans, New Orleans, LA | 12/2001 |
| State/Local Invited Seminars/Lectures, Hypertension in the Elderly, American Society of Hypertension Gulf Central Chapter, New Orleans, LA | 11/2001 |
| Poster Presentation, The Morton Have-A-Heart Adolescent Obesity Project: A School-Based Program to Heighten Awareness Among Medicine-Pediatric Residents, First National CDC Prevention Conference on Heart Disease and Stroke, Atlanta, GA | 08/2001 |
| Poster Presentation, Screening for Primary Aldosterone in Older Patients with Hypertension, 16th Scientific Meeting of the American Society of Hypertension, San Francisco, CA | 05/2001 |
| State/Local Invited Seminars/Lectures, Hypertension in the Elderly, Delta Medical Society, Greenwood Leflore Hospital, Greenwood, MS | 04/2001 |
| State/Local Invited Seminars/Lectures, Clinicopathologic Conference (CPC) - Medicine Resident Noon Conference, The University of Mississippi Medical Center, Jackson, MS | 11/2000 |
| State/Local Invited Seminars/Lectures, A Focus on Systolic Hypertension in the Elderly, University of Mississippi Medical Center Grand Rounds, Jackson, MS | 11/2000 |
| National and International Invited Seminars/Lectures, Why Focus on Systolic Blood Pressure, National Scientific Sessions of Consortium for Southeastern Hypertension Control, Savannah, Georgia | 11/2000 |
| Poster Presentation, Improvement in Blood Pressure Control through Interdisciplinary Medication Assistance Efforts in Hypertensive Patients with Multiple Metabolic Syndrome, Mississippi Nurse=s Association Annual Convention, Biloxi, MS | 10/2000 |
| Poster Presentation, Women=s Health Initiative of Mississippi: An Innovative Approach to Promoting Wellness, North American Association for the Study of Obesity, Annual Meeting, Long Beach, CA | 10/2000 |
| State/Local Invited Seminars/Lectures, Mental Health Issues of Women, Mississippi Department of Mental Health First Annual Conference on Alzheimer’s Disease and Psychiatric Disorders in the Elderly, Biloxi, MS | 08/2000 |
| National and International Invited Seminars/Lectures, Implications of Obesity Guidelines to the Atherosclerosis Risk in Communities Cohort, The International Society on Hypertension in Blacks, Las Croabas, Puerto Rico | 06/2000 |
| Poster Presentation, Evaluation of Compliance with National Cholesterol Education Program Recommendations for Screening and Treatment of Hyperlipidemia in Medical Resident Primary Care Training Clinics, 15th Scientific Meeting of the American Society of Hypertension, New York, NY | 05/2000 |
| National and International Invited Seminars/Lectures, Screening for Primary Aldosteronism in Hypertension Patients, The American Society of Hypertension, New York, New York | 05/2000 |
| State/Local Invited Seminars/Lectures, State Department of Health’s First Disparities Conference, Jackson Medical Mall, Jackon, MS | 03/2000 |
| National and International Invited Seminars/Lectures, Alpha and Beta Blockade in Obese versus Lean Hypertensives, American Heart Association 52nd Annual Fall Conference, Philadelphia, PA | 09/1998 |
| State/Local Invited Seminars/Lectures, Department of Medicines Division Directors Retreat, Mentoring in an Academic medicine Setting: Ideas for Improvement at All Levels, Philadelphia, MS | 04/1998 |
| State/Local Invited Seminars/Lectures, Mississippi Hypertension Disease Management Network, Cleveland, MS | 03/1998 |
| State/Local Invited Seminars/Lectures, Department of Medicines Resident Retreat, Annual Resident Orientation, Jackson, MS | 1998 |
| Regional Invited Seminars/Lectures, Hypertension in the Southeast, The Mississippi Cooperative Hypertension Evaluation and Treatment Network, Delta Regional Medical Center, Continuing Medical Education | 06/1997 |
| State/Local Invited Seminars/Lectures, Computers in Medicine: the Implementation of SMS, Grand Rounds, University of Mississippi, Department of Medicine, Jackson, MS | 06/1997 |
| Poster Presentation, Effects of Weight Loss Intervention in HOT Weight Loss Substudy Participants, American Society of Hypertension, San Francisco, CA | 05/1997 |
Honors, Awards, and Recognition
| Best Doctors in America | 2011 |
| Gold Level Award for Excellence in Research, University of Mississippi Medical Center | 2011 |
| Herbert G Langford Professor of Medicine | 2010 |
| Specialist in Clinical Hypertension:American Society of Hypertension | 2009 |
| Silver Level Award for Excellence in Research, Univeristy of Mississippi Medical Center | 2006 |
| Who's Who in Medicine and Healthcare | 2004 |
| Alliance for Academic Internal Internal Medicine-Merck Executive Leadership Program | 2004 |
| Fellow of American Heart Association Council for High Blood Pressure Research | 2003 |
| Best Doctors in America | 2001 |
| Fellow of the American College of Physicians | 2001 |
| Best Doctors in America | 1998 |
| American Society of Hypertension Bristol-Myers Squibb Recognition Award | 1996 |
| Hellums Award- House Officer of the Year, Department of Medicine University of Mississippi Medical Center | 1995 |
| Quality Care Award, Department of Veterans Affairs | 1995 |
| Omicron Delta Kappa Honorary Society, Millsaps College | 1975 |
| Sigma Lambda Leadership Honorary, Millsaps College | 1975 |
| Vice President fo Student Body, Millsaps College | 1975 |
| Who's Who Among Students in American Univeristies and Colleges, Millsaps College | 1975 |
| President of third and fourth year medical school classes, University of Mississippi Medical Center |
Professional Membership and Service
| The American Society of Hypertension, Inc., Member-at-Large, Gulf Coast Regional Chapter | 2010 - Present |
| American Society of Hypertension, Committee Member, specialists exam committee meeting | 2008 |
| American Heart Association, Committee Member, Scientific Grant Review committee | 2008 - Present |
| American Society of Hypertension, Committee Member, Nominating Committee Meeting | 2008 |
| Chronic Disease Program, Medical Consultant | 2008 - Present |
| The American Society of Hypertension, Inc., Member, Hypertension Specialist Exam Committee | 2008 - Present |
| USMLE Step 3 Scripting Committee, Member | 2008 - Present |
| The American Society of Hypertension, Inc., Member, The American Society of Hypertension, Inc. Hypertension Specialist Exam Committee 2008 -2013 | 2008 - 2013 |
| American Heart Association, Chairperson, Go Red for Women Luncheon | 2008 - 2009 |
| American Society of Hypertension, Committee Member, National Leadership forum | 2008 |
| American Society of Hypertension, Committee Member, Program Committee meeting | 2007 |
| American Society of Hypertension, Committee Member, Regional Chapters Presidents meeting | 2007 |
| The American Society of Hypertension Gulf Coast Regional Chapter, Officer, President/Elect/Past | 2006 - Present |
| Mississippi Blue Cross/Blue Shield Metabolic Syndrome Committee, Medical Consultant | 2006 - 2009 |
| The American Society of Hypertension, Inc., Officer, President/Elect/Past, Gulf Coast Regional Chapter | 2006 - 2009 |
| The Journal of Clinical Hypertension, Reviewer, Journal Article | 2005 - Present |
| The American Society of Hypertension, Inc., Officer, Vice President, Gulf Coast Regional Chapter | 2005 - 2006 |
| National Board of Medical Examiners, USMLE, Member, Step 3 Computer-Based Case Simulation | 2004 - 2008 |
| American Heart Association, Member, Council on High Blood Pressure Research | 2003 - Present |
| The Wilson Research Foundation, Board of Governors | 2003 - Present |
| The American Society of Hypertension, Inc., Committee Member | 2003 - 2009 |
| The American Society of Hypertension, Inc., Member, Membership Committee, 2003 – 2009 | 2003 - 2009 |
| The American Society of Hypertension, Committee Member, Gulf Coast Regional Chapter | 2002 - Present |
| USMLE, Committee Member, CCS- testing committee | 2002 - Present |
| Hypertension Journal of the American Heart Association, Editorial Review Board Member | 2002 - 2007 |
| 18th Scientific Meeting of the International Society of Hypertension, Abstract Reviewer | 2000 - Present |
| Southern Medical Journal, Reviewer, Journal Article | 2000 - 2005 |
| American Society of Hypertension, Member, Gulf Central Regional Chapter | 2000 - Present |
| Cardiovascular Disease Ad Hoc Committee, Committee Vice Chair, Mississippi Department of Health- Mississippi Chronic Illness Coalition | 2000 - Present |
| Consortium for Cardiovascular Disease Prevention Strategies in Mississippi, Sterring Comittee Member | 2000 - Present |
| Journal of Medical Sciences, Editorial Review Board Member | 1999 - Present |
| The Journal of Medical Sciences, Editorial Review Board Member | 1999 - 2005 |
| Women's Health Inititative of Mississippi, Board of Directors of a Company | 1999 - Present |
| American Society of Hypertension, Member, ASH Specialist in Clinical Hypertension | 1999 - 2009 |
| Central Medical Society of Mississippi, Member, State Delegate | 1999 |
| Mississippi State Department of Health, Consultant, Chronic Disease Program | 1998 |
| Southern Society for Clinical Investigation, Member | 1997 - Present |
| American Medical Association, Member | 1997 - 2010 |
| International Society on Hypertension in Blacks, Member | 1997 - 2002 |
| The American Society of Hypertension, Member | 1996 - Present |
| Wilderness Ventures, Inc., Program Coordinator, Summer Course Director | 1982 - 1991 |
| Jackson Preparatory High School, Instructor, Biology | 1980 - 1988 |
| American College of Physicians, Member | |
| American Federation for Medical Research, Member | |
| American Society of Internal Medicine, Member | |
| Consortium for Southeastern Hypertension Control, Member | |
| Mississippi State Medical Society, Member | |
| Society of General Internal Medicine, Member | |
| Southern Medical Association, Member |
Committee Service
| ASH Nominating Committee, Member | 2013 - 2014 |
| ASH Specialitst Program Examination Committee, Member | 2013 - 2014 |
| Student Employee Task Force, Member | 2012 - Present |
| Epic Steering Committee, Member | 2011 - Present |
| Department of Medicine Clinical Council, Member | 2011 - 2012 |
| Department of Medicine Promotions and Tenure Committee, Member | 2011 - 2012 |
| Medical Center - Research Advisory Committee, Member | 2007 - Present |
| Medical Center - Institutional Quality Board, Member | 2007 - 2008 |
| Medical Center - Conflict Of Interest, Member | 2006 - Present |
| The University Hospitals and Clinics - Accreditation and Bylaws, Chair | 2000 - 2001 |
| School of Medicine- Research Development Committee, Member | 2000 - Present |
| Medical Center- Appeals and Grievance Committee, Member | 2000 - 2000 |
| The University Hospitals and Clinics - Accreditation and Bylaws, Member | 1999 - 2000 |
| Medical Center - Compliance, Member | 1999 - Present |
| Medical Center - Research Advisory Committee, Member | 1999 - 2004 |
| School Of Graduate Studies - Graduate Council, Member | 1998 - Present |
| School Of Medicine - Residency Review Subcommittee, Member | 1998 - 2000 |
| Medical Center- House Officer Selection Committee, Member | 1997 - 2002 |
| School of Medicine- Medical Education Committee, Member | 1996 - 1997 |
| Quality and Assurance Committee, Member | 1995 - 1995 |
| School of Medicine- Self Study Committee, Member | 1995 - 1995 |
| The University Hospitals and Clinics - Pharmacy and Therapeutics, Member | 1995 - 1995 |
Other Service
| Chief of Medical Staff | 2011 - Present |
| University Mississippi Medical Center Medical Staff, Vice Chief | 2009 - 2011 |
| Institutional Quality Board, Member | 2007 - 2008 |
| Research Strategic Task Force, Member | 2003 - 2006 |
| Department of Medicine Research Council, Member | 2001 - Present |
| Heath Insurance Portability and Accountability Act, Member | 2000 - 2007 |
| Clinical Research Program, Director | 1999 - Present |
| Education Council, Member | 1998 - 2002 |
| Division of Hypertension, Education Coordinator | 1998 - 2000 |
| Introduction to Clinical Medicine, Preceptor | 1998 - 2000 |
| Residency Program Department of Medicine, Associate Program Director | 1998 - 2000 |
| Ambulatory Medicine, Attending Member | 1997 - Present |
| Center for Excellence in Cardiovascular-Renal Research, Member | 1997 - Present |
| General Medicine Teaching Service, Attending Member | 1997 - Present |
| Microbiology Laboratory, Technician | 1989 - 1989 |
Teaching Experience
| 621, Medicine, Course, Preceptor, Introduction to Clinical Medicine | Spring 2013 |
| 621, Medicine, Course, Preceptor, Introduction to Clinical Medicine | Fall 2012 |
| 621, Medicine, Small Group, Guest Presenter, Introduction to Clinical Medicine | Spring 2012 |
| 621, Medicine, Course, Preceptor, Introduction to Clinical Medicine | Spring 2012 |
| 621, Medicine, Course, Preceptor, Introduction to Clinical Medicine | Fall 2011 |
| 621, Medicine, Small Group, Guest Presenter, Introduction to Clinical Medicine | Fall 2011 |
| Lecture, Lecturer, Mandatory Resident Conference | Spring 2011 |
| Lecture, Lecturer, Consortium for Southeastern Hypertension Control | Summer 2010 |
Directed Student Learning
| Mentor, Advised: Julie Raviero | 2011 - 2011 |